Pricing
Priced in HCC. Transparent. Tiered by who you are.
You pay in HEALTHCARE-Coin (HCC) — the same token patients earn for sharing data — so every dollar you spend on access flows back into the participants whose lives you're studying. Three tiers. Rates posted. No quotes, no negotiation theater.
What is HCC?
HEALTHCARE-Coin (HCC) is the data-economy token. Researchers buy it on hc.exchange, spend it for enclave access. ~70% of every spend routes back to participants in the queried cohort, ~20% to platform operations, ~10% to the patient-data trust. Indicative rate updated daily.
For published research.
- Up to 10 queries / day
- Up to 50,000 cohort rows
- Standard schema (OMOP + CH axis extensions)
- Same-day output review
- JupyterLab + RStudio + DBeaver in enclave
- One PI + 3 collaborators
- Pre-print + DOI assignment
- Custom schema extensions
- Dedicated enclave node
For most published work.
- Up to 50 queries / day
- Up to 250,000 cohort rows
- Standard + 3 schema extensions
- Same-day output review · 4h SLA
- JupyterLab + RStudio + DBeaver + custom Python deps
- One PI + 8 collaborators
- Pre-print + DOI + chain-pinned analytic plan
- Quarterly liaison-call
- Dedicated enclave node
For pipeline-impacting work.
- Unlimited queries (fair-use)
- Unlimited cohort size
- Custom schema extensions
- Priority output review · 1h SLA
- Dedicated enclave node + custom workspace
- Up to 25 collaborators
- Cohort co-design + recruitment support
- Monthly steering call · ELN integration
- Optional commercial-publication review
All tiers include free pre-application call · IRB review · DUA · output review. There are no per-query, per-row, or per-result fees on top.
Live calculator
Estimate your study, in HCC.
Move the sliders to your protocol's actual scope; toggle add-ons. Updates as you go. The estimate is what we'd quote, not theater.
Scope
Add-ons
Always included
Things that aren't extras.
Other registries charge for many of these. We don't.
À la carte
Optional add-ons.
| Add-on | What you get | HCC | Indicative USD |
|---|---|---|---|
| Dedicated enclave node | Single-tenant compute · 8-vCPU / 64 GB / 2 TB · isolated networkAvoids contention with other studies during heavy runs. | +15,000 | ~$12,600 |
| Cohort co-design + recruitment | Our team helps design the cohort and recruit additional participants meeting your inclusion criteriaUseful when the natural cohort is below the n you need. | +8,000 | ~$6,720 |
| ELN / lab-system integration | Direct connector to your electronic-lab-notebook (Benchling, LabKey)Auto-syncs query outputs into your study workspace. | +5,000 | ~$4,200 |
| Priority output review (1h SLA) | Output reviews returned within 1 hour during business hoursFor grant deadlines and conference cycles. | +3,500 | ~$2,940 |
| Pediatric / SUD / BH escalation | Second-tier IREB review with patient-advocate seatRequired for sensitive populations; pre-app call will tell you if you need this. | +2,000 | ~$1,680 |
| Schema extension (per field) | New field surfaced in the enclave from upstream sourcesAverage 7-day turnaround. Some fields require additional consent. | +750 | ~$630 |
| Re-run on updated cohort | Re-execute your study against the next 12-month data windowNo new IRB needed if analytic plan unchanged. | +1,500 | ~$1,260 |
Why we price in HCC
Because the people whose data you're using earned it.
Patients earn HCC for contributing data to research-eligible registries — measured against the eight axes of the Master Equation. When you pay in HCC, you're spending the same instrument they earn. About 70% of every research spend flows back to the queried cohort proportional to contribution.
This is not a cosmetic detail. It closes a loop the rest of the registry industry has left open for thirty years: the participants who made the science possible, finally on the receipts.
And because the price stays honest.
HCC trades on hc.exchange with public order books. We don't quote in dollars because dollars hide what's happening — variable academic discounts, opaque deal-by-deal pharma pricing, etc. The HCC price is the same for everyone in a tier; the USD-indicative number floats with the market.
You can buy HCC at any time, hold it across studies, and see exactly what your access cost in the same units the patients are tracking.
Questions about pricing
Pricing FAQ.
Do we have to buy HCC ourselves?
No. You can wire fiat USD; we'll execute the HCC purchase at the time-of-receipt indicative rate, hand you the receipt with both numbers. About 60% of academic Tier-1 customers do this.
What if our grant only allows USD payments?
USD invoicing is standard for academic and commercial customers. We treat HCC as the unit-of-account; USD is the payment-rail.
Can a foundation grant cover the access fee?
Yes, common. We'll provide grant-compatible invoicing and outcomes documentation. Many foundations explicitly fund data-access fees as direct costs.
What's the refund policy if our IRB doesn't approve?
Full refund minus a 250 HCC review fee if you've gotten as far as IREB approval. Pre-application calls and protocol drafting are free regardless of outcome. We don't charge for things that don't happen.
Are there per-query or per-result charges?
No. Within your tier's daily-query quota and cohort size, queries and outputs are unmetered. Output review is unmetered. We've designed pricing to not punish good methodology — exploring before settling on the final cohort is encouraged.
Can multiple PIs share access?
Within one study, yes (collaborator slots per tier). Across distinct studies, separate access fees apply because the IRB and DUA are study-specific. Multi-study institutional licensing is available — contact us.
How are participants paid?
When you pay your access fee, ~70% routes to a study-specific cohort pool on chain. Each participant whose data appeared in your queries earns a share proportional to records contributed. They see it in their Patient app the next day.
When you're ready
Apply with a real estimate in hand.
The calculator gives you a number; the application form lets you discuss it with us. You can keep the estimate as your reference if budgets change.